Trends in 30- and 90-Day Readmission Rates for Heart Failure
Muhammad Shahzeb Khan(University of Mississippi Medical Center), Javed Butler(Jackson Memorial Hospital), Marwan S. Abougergi(University of South Carolina), Noman Lateef(Creighton University), Jayakumar Sreenivasan(Westchester Medical Center), Gregg C. Fonarow(UCLA Medical Center), Stefan D. Anker(Bayer (Germany)), Tariq Ahmad(Karachi Medical and Dental College), Stephen J. Greene(Duke Medical Center)
Cited by 267
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k